|
|
||||||||
The Journal of Thoracic and Cardiovascular Surgery, Vol 103, 887-893, Copyright © 1992 by The American Association for Thoracic Surgery and The Western Thoracic Surgical Association
KS Naunheim, P Petruska, TS Roy, CH Andrus, FE Johnson, JM Schlueter and AE Baue
From October 1986 to January 1991, 47 patients with esophageal cancer (29
squamous, 18 adenocarcinoma) were treated with simultaneous radiotherapy
(3000 or 3600 cGy) and chemotherapy (infusional 5- fluorouracil, cisplatin)
delivered during a 5-week period. This treatment was well tolerated; 44
patients (94%) completed a full course of therapy, 40 (85%) had relief from
dysphagia, and 21 (45%) noted either weight gain or no net weight loss. One
patient (2%) died of complications (tracheoesophageal fistula, perforated
ulcer) during chemotherapy and radiotherapy. The remaining 46 patients were
referred for operation. Six refused because of excellent relief of their
dysphagia, and one was denied operation. Thirty-nine patients went to
operation, and 34 (83%) had lesions that were resectable. Eight of the 39
surgically treated patients (21%) had no evidence of residual tumor
identified in the resected specimens. One of these complete responders died
7 weeks postoperatively after multiple complications (3% operative
mortality rate). Three of the remaining seven have also died since the
operation, one of recurrent cancer and two with no known recurrent disease.
Actuarial survival in this present series was significantly better than
that of our 1980 to 1985 historical control patients (p less than 0.005).
There was no difference between patients with squamous carcinoma and those
with adenocarcinoma with regard to the prevalence of complete response or
long-term survival. Survival of the seven patients who did not undergo
operation was comparable with that of the 34 patients in whom esophagectomy
was performed. This study suggests that combined preoperative chemotherapy
plus radiotherapy for esophageal cancer is well tolerated, provides
excellent palliation of symptoms, allows for a high rate of resectability,
is equally effective for squamous carcinoma and adenocarcinoma, and
provides encouraging early results with regard to long-term survival. The
data also call into question the role of esophagectomy, particularly in
patients who have a complete response to preoperative therapy.
ARTICLES
Preoperative chemotherapy and radiotherapy for esophageal carcinoma
Department of Surgery, St. Louis University Medical Center, Mo. 63110- 0250.
This article has been cited by other articles:
![]() |
H.-S. Lee, J. M. Lee, M. S. Kim, H. Y. Kim, B. Hwangbo, and J. I. Zo Low-Dose Steroid Therapy at an Early Phase of Postoperative Acute Respiratory Distress Syndrome Ann. Thorac. Surg., February 1, 2005; 79(2): 405 - 410. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. E. Avendano, P. A. Flume, G. A. Silvestri, L. B. King, and C. E. Reed Pulmonary complications after esophagectomy Ann. Thorac. Surg., March 1, 2002; 73(3): 922 - 926. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Nishimura, H. Osugi, K. Inoue, N. Takada, M. Takamura, and H. Kinosita Bronchoscopic Ultrasonography in the Diagnosis of Tracheobronchial Invasion of Esophageal Cancer J. Ultrasound Med., January 1, 2002; 21(1): 49 - 58. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. R. Jones, F. C. Detterbeck, T. M. Egan, L. A. Parker Jr, S. A. Bernard, and J. E. Tepper Induction Chemoradiotherapy Followed by Esophagectomy in Patients With Carcinoma of the Esophagus Ann. Thorac. Surg., July 1, 1997; 64(1): 185 - 192. [Abstract] [Full Text] |
||||
![]() |
N. K. Altorki and D. B. Skinner OCCULT CERVICAL NODAL METASTASIS IN ESOPHAGEAL CANCER: PRELIMINARY RESULTS OF THREE-FIELD LYMPHADENECTOMY J. Thorac. Cardiovasc. Surg., March 1, 1997; 113(3): 540 - 544. [Abstract] [Full Text] |
||||
![]() |
S. G. Swisher, E. C. Holmes, K. K. Hunt, J. E. Doty, M. J. Zinner, and D. W. McFadden The Role of Neoadjuvant Therapy in Surgically Resectable Esophageal Cancer Arch Surg, August 1, 1996; 131(8): 819 - 825. [Abstract] [PDF] |
||||
![]() |
K. W. Millikan, J. Silverstein, V. Hart, K. Blair, S. Bines, J. Roberts, and A. Doolas A 15-Year Review of Esophagectomy for Carcinoma of the Esophagus and Cardia Arch Surg, June 1, 1995; 130(6): 617 - 624. [Abstract] [PDF] |
||||
![]() |
K. S. Naunheim, P. J. Petruska, T. S. Roy, J. M. Schlueter, H. Kim, and A. E. Baue Multimodality therapy for adenocarcinoma of the esophagus Ann. Thorac. Surg., May 1, 1995; 59(5): 1085 - 1091. [Abstract] [PDF] |
||||
![]() |
C. D. Wright, D. J. Mathisen, J. C. Wain, H. C. Grillo, A. D. Hilgenberg, A. C. Moncure, R. W. Carey, N. C. Choi, M. Daly, and D. L. Logan Evolution of treatment strategies for adenocarcinoma of the esophagus and gastroesophageal junction Ann. Thorac. Surg., December 1, 1994; 58(6): 1574 - 1579. [Abstract] [PDF] |
||||
![]() |
J. S. McLaughlin Induction therapy for squamous carcinoma of the thoracic esophagus: The continuing journey Ann. Thorac. Surg., May 1, 1994; 57(5): 1064 - 1065. [PDF] |
||||
![]() |
K. S. Naunheim, J. Hanosh, J. Zwischenberger, M. W. Turrentine, K. A. Kesler, L. B. Reeder, M. K. Ferguson, and A. E. Baue Esophagectomy in the septuagenarian Ann. Thorac. Surg., October 1, 1993; 56(4): 880 - 884. [Abstract] [PDF] |
||||
![]() |
S. J. Hoff, J. R. Stewart, J. L. Sawyers, M. J. Murray, W. H. Merrill, R. B. Adkins, and D. H. Johnson Preliminary results with neoadjuvant therapy and resection for esophageal carcinoma Ann. Thorac. Surg., August 1, 1993; 56(2): 282 - 287. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |